Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Danilenko

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Voprosy Onkologii|March 10, 2010
[Investigation of antitumor activity of the hexamer fraction of HLDF-6 peptide as a differentiation factor in hemoblastoma-bearing mice]E D Danilenko, G M Sysoeva, S Iu Ustimenko, et al.
Bulletin of Experimental Biology and Medicine|January 20, 2011
Pharmacokinetics and antitumor effects of the drug containing TNF-α in nanoparticlesS G Gamaley, A V Bateneva, G M Sysoeva, et al.
Bulletin of Experimental Biology and Medicine|June 11, 2009
Antitumor and immunomodulating effects of a fragment of HL-60 cell differentiation factor in mice with lewis pulmonary carcinomaG M Sysoeva, V A Fadina, E D Danilenko, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|October 1, 2004
[Effects of the dsRNA interferon inducer on the interaction between macrophages and Mycobacterium tuberculosis in vitro]V I Masycheva, L N Chernouso va, E D Danilenko, et al.
Voprosy Virusologii|August 14, 2002
[Effect of tumor necrosis factor alpha on the efficiency of anti-rabies vaccination]A M Shestopalov, Iu N Rassadkin, E N Ustinova, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|December 8, 2011
[Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice]M O Skarnovich, L N Shishkina, A S Kabanov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1997
[Toxic properties of recombinant tumor necrosis factor]V I Masycheva, E D Danilenko, E N Morozova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 8, 2010
[Antitumor properties of a liposomal form of a differentiation factor HLDF fragment in cultured cells]A V Bateneva, O A Babenko, E D Danilenko, et al.
Voprosy Virusologii|November 6, 2003
[The impact of compound of double-stranded RNA and hyaluronic acid on the parameters of non-specific resistance in mice]V I Masycheva, E D Danilenko, N N Shkil', et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 21, 2001
[Study of the antiviral activity, pharmacokinetics and toxic properties of liposomal form of human alpha-2b interferon administered topically]V V Zolin, O A Agafonova, A A Kolokol'tsov, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Voprosy Onkologii|March 10, 2010
[Investigation of antitumor activity of the hexamer fraction of HLDF-6 peptide as a differentiation factor in hemoblastoma-bearing mice]E D Danilenko, G M Sysoeva, S Iu Ustimenko, et al.
Bulletin of Experimental Biology and Medicine|January 20, 2011
Pharmacokinetics and antitumor effects of the drug containing TNF-α in nanoparticlesS G Gamaley, A V Bateneva, G M Sysoeva, et al.
Bulletin of Experimental Biology and Medicine|June 11, 2009
Antitumor and immunomodulating effects of a fragment of HL-60 cell differentiation factor in mice with lewis pulmonary carcinomaG M Sysoeva, V A Fadina, E D Danilenko, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|October 1, 2004
[Effects of the dsRNA interferon inducer on the interaction between macrophages and Mycobacterium tuberculosis in vitro]V I Masycheva, L N Chernouso va, E D Danilenko, et al.
Voprosy Virusologii|August 14, 2002
[Effect of tumor necrosis factor alpha on the efficiency of anti-rabies vaccination]A M Shestopalov, Iu N Rassadkin, E N Ustinova, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|December 8, 2011
[Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice]M O Skarnovich, L N Shishkina, A S Kabanov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1997
[Toxic properties of recombinant tumor necrosis factor]V I Masycheva, E D Danilenko, E N Morozova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 8, 2010
[Antitumor properties of a liposomal form of a differentiation factor HLDF fragment in cultured cells]A V Bateneva, O A Babenko, E D Danilenko, et al.
Voprosy Virusologii|November 6, 2003
[The impact of compound of double-stranded RNA and hyaluronic acid on the parameters of non-specific resistance in mice]V I Masycheva, E D Danilenko, N N Shkil', et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 21, 2001
[Study of the antiviral activity, pharmacokinetics and toxic properties of liposomal form of human alpha-2b interferon administered topically]V V Zolin, O A Agafonova, A A Kolokol'tsov, et al.
Pageof 3